• 
  Marie-Christine Pandolfino, Christophe Viret, Nadine Gervois, Yannick Guilloux, François Davodeau, et al.. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes. European Journal of Immunology, Wiley-VCH Verlag, 1992, 22 (7), pp.1795-1802. ⟨10.1002/eji.1830220719⟩. ⟨inserm-03350961⟩
• 
  Yannick Guilloux, Christophe Viret, Nadine Gervois, Eric Le Dréan, Marie-Christine Pandolfino, et al.. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cellsin vitro. European Journal of Immunology, Wiley-VCH Verlag, 1994, 24 (9), pp.1966-1973. ⟨10.1002/eji.1830240905⟩. ⟨inserm-03350944⟩
• 
  Eric Le Dréan, Nadine Gervois, Elisabeth Diez, Gilbert Semana, Brigitte Dreno, et al.. HLA class II-restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes. European Journal of Immunology, Wiley-VCH Verlag, 1995, 25 (10), pp.2732-2736. ⟨10.1002/eji.1830251003⟩. ⟨inserm-03350939⟩
• 
  Christophe Viret, Nadine Gervois, Yannick Guilloux, Eric Le Drean, Elisabeth Diez, et al.. T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro. International Immunology, Oxford University Press (OUP), 1995, 7 (10), pp.1535-1543. ⟨10.1093/intimm/7.10.1535⟩. ⟨inserm-03350933⟩
• 
  Nadine Gervois, Yannick Guilloux, Elisabeth Diez, Francine Jotereau. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. Journal of Experimental Medicine, Rockefeller University Press, 1996, 183 (5), pp.2403-7. ⟨10.1084/jem.183.5.2403⟩. ⟨inserm-03350925⟩
• 
  Pedro Romero, Nadine Gervois, Jens Schneider, Patricia Escobar-Páramo, Danila Valmori, et al.. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 1997, 159 (5), pp.2366-74. ⟨inserm-03350147⟩
• 
  L. Toujas, J.-G Delcros, E. Diez, Nadine Gervois, G. Semana, et al.. Human monocyte‐derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I‐restricted exogenous peptides. Immunology, Wiley, 1998, 91 (4), pp.635-642. ⟨10.1046/j.1365-2567.1997.00287.x⟩. ⟨inserm-03350111⟩
• 
  Jean-François Fonteneau, E Le Dréan, S Le Guiner, Nadine Gervois, E Diez, et al.. Heterogeneity of biologic responses of melanoma-specific CTL. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 1997, 159 (6), pp.2831-9. ⟨inserm-03350085⟩
• 
  Eric Le Dréan, Frédéric Vély, Lucia Olcese, Anna Cambiaggi, Sophie Guia, et al.. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. European Journal of Immunology, Wiley-VCH Verlag, 1998, 28 (1), pp.264-76. ⟨10.1002/(SICI)1521-4141(199801)28:013.0.CO;2-O⟩. ⟨inserm-03350053⟩
• 
  Danila Valmori, Jean-François Fonteneau, Concepcion Maranon Lizana, Nadine Gervois, Danielle Liénard, et al.. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2021, 160 (4), pp.1750-8. ⟨inserm-03350030⟩
• 
  Edouard Samarut, Alexandre Lugat, Aymeric Amelot, Emeric Scharbarg, Samy Hadjadj, et al.. Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma. Journal of Neuro-Oncology, Springer Verlag, 2021, 152 (1), pp.115 - 123. ⟨10.1007/s11060-020-03683-6⟩. ⟨inserm-03349991⟩
• 
  Alexandre Lugat, Pauline Hulo, Catherine Ansquer, Yann Touchefeu, Eric Mirallié, et al.. Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative 18F-FDG PET/CT: Don’t Forget the Thyroid!. Current Oncology, Multimed Inc., 2021, 28 (4), pp.2987 - 2992. ⟨10.3390/curroncol28040261⟩. ⟨inserm-03349985⟩
• 
  Olivier Espitia, Jérémy Schanus, Christian Agard, Françoise Kraeber-Bodéré, Jeanne Hersant, et al.. Specific features to differentiate Giant cell arteritis aortitis from aortic atheroma using FDG-PET/CT. Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.17389. ⟨10.1038/s41598-021-96923-2⟩. ⟨inserm-03349976⟩
• 
  Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, et al.. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study. Journal of Nuclear Medicine, Society of Nuclear Medicine, 2021, 62 (9), pp.1221 - 1227. ⟨10.2967/jnumed.120.252791⟩. ⟨inserm-03349968⟩
• 
  Luis Paz-Ares, Tudor-Eliade Ciuleanu, Manuel Cobo, Michael Schenker, Bogdan Zurawski, et al.. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial. Lancet, Elsevier, 2021, 22 (2), pp.198-211. ⟨10.1016/S1470-2045(20)30641-0⟩. ⟨inserm-03349944⟩
• 
  Zixian Jin, Jianfei Shen, Chunguo Wang, Dong Chen, Bo Zhang, et al.. Narrative review of pembrolizumab for the treatment of esophageal cancer: evidence and outlook. Annals of translational medicine, AME Publishing Company, 2021, 9 (14), pp.1189 - 1189. ⟨10.21037/atm-21-2804⟩. ⟨inserm-03349940⟩
• 
  Mathias Declercq, Lucas Treps, Siham Bousfia, Peter Carmeliet, Peter Witters. Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension. European Respiratory Journal, European Respiratory Society, 2021, 58 (2), pp.2101645. ⟨10.1183/13993003.01645-2021⟩. ⟨inserm-03349937⟩
• 
  Lucas Treps, Mathias Declercq, Siham Bousfia, Peter Carmeliet, Peter Witters. Comparative meta-analysis of cystic fibrosis cell models suggests partial endothelial-to-mesenchymal transition. Journal of Cystic Fibrosis, Elsevier, 2021, pp.S1569-1993(21)00101-6. ⟨10.1016/j.jcf.2021.03.019⟩. ⟨inserm-03349936⟩
• 
  Lucas Treps, Sébastien Faure, Nicolas Clere. Vasculogenic mimicry, a complex and devious process favoring tumorigenesis -Interest in making it a therapeutic target. Pharmacology & Therapeutics Part A Chemotherapy Toxicology and Metabolic Inhibitors, Elsevier, 2021, 223, pp.107805. ⟨10.1016/j.pharmthera.2021.107805⟩. ⟨inserm-03349934⟩
• 
  Marion Grard, Camille Chatelain, Tiphaine Delaunay, Elvire Pons-Tostivint, Jaafar Bennouna, et al.. Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy. Frontiers in Oncology, Frontiers, 2021, 11, pp.695770. ⟨10.3389/fonc.2021.695770⟩. ⟨inserm-03349933⟩

42 081